Given the diverse functions of c-Myc, including cycle regulation and cell proliferation, it is associated with 20% of human cancers, and its promotion of the cell cycle in carcinoma cells induces the expression of CDKs, cyclins and the E2F family and inhibits CDKs inhibitors 32, 49. Here, MYC is linked to carcinoma.